title: Negative autoregulation by Fas stabilizes adult erythropoiesis and accelerates its stress response.
abstract: Erythropoiesis maintains a stable hematocrit and tissue oxygenation in the basal state, while mounting a stress response that accelerates red cell production in anemia, blood loss or high altitude. Thus, tissue hypoxia increases secretion of the hormone erythropoietin (Epo), stimulating an increase in erythroid progenitors and erythropoietic rate. Several cell divisions must elapse, however, before Epo-responsive progenitors mature into red cells. This inherent delay is expected to reduce the stability of erythropoiesis and to slow its response to stress. Here we identify a mechanism that helps to offset these effects. We recently showed that splenic early erythroblasts, 'EryA', negatively regulate their own survival by co-expressing the death receptor Fas, and its ligand, FasL. Here we studied mice mutant for either Fas or FasL, bred onto an immune-deficient background, in order to avoid an autoimmune syndrome associated with Fas deficiency. Mutant mice had a higher hematocrit, lower serum Epo, and an increased number of splenic erythroid progenitors, suggesting that Fas negatively regulates erythropoiesis at the level of the whole animal. In addition, Fas-mediated autoregulation stabilizes the size of the splenic early erythroblast pool, since mutant mice had a significantly more variable EryA pool than matched control mice. Unexpectedly, in spite of the loss of a negative regulator, the expansion of EryA and ProE progenitors in response to high Epo in vivo, as well as the increase in erythropoietic rate in mice injected with Epo or placed in a hypoxic environment, lagged significantly in the mutant mice. This suggests that Fas-mediated autoregulation accelerates the erythropoietic response to stress. Therefore, Fas-mediated negative autoregulation within splenic erythropoietic tissue optimizes key dynamic features in the operation of the erythropoietic network as a whole, helping to maintain erythroid homeostasis in the basal state, while accelerating the stress response.
authors.affiliation: Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
authors.forename: Miroslav
authors.initials: M
authors.lastname: Koulnis
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Kelly
authors.initials: K
authors.lastname: Hallstrom
authors.forename: Merav
authors.initials: M
authors.lastname: Socolovsky
mesh_terms: D000375:Aging / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001272:Atmosphere; D015687:Cell Hypoxia / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003114:Colony-Forming Units Assay; D004900:Erythroblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000494:pharmacology; D053222:Fas Ligand Protein / Q000172:deficiency; D018398:Homeodomain Proteins / Q000378:metabolism; D006706:Homeostasis / Q000187:drug effects; D051379:Mice; D008954:Models, Biological; D010100:Oxygen / Q000494:pharmacology; D011961:Receptors, Fc / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013154:Spleen / Q000166:cytology; D013312:Stress, Physiological / Q000187:drug effects; D019014:fas Receptor / Q000172:deficiency / Q000378:metabolism*
chemical_list: D053222:Fas Ligand Protein; C491899:Fas protein, mouse; D018398:Homeodomain Proteins; D011961:Receptors, Fc; D019014:fas Receptor; D004921:Erythropoietin; C064658:RAG-1 protein; D010100:Oxygen